{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:24:59Z","timestamp":1767770699149,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":33,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006744.pub2","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T14:39:23Z","timestamp":1256135963000},"source":"Crossref","is-referenced-by-count":25,"title":["Alpha blockers prior to removal of a catheter for acute urinary retention in adult men"],"prefix":"10.1002","author":[{"given":"Hans-Joerg","family":"Zeif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesavapillai","family":"Subramonian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD006744.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-410X.2005.05299.x","article-title":"Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia","volume":"95","author":"Lucas","year":"2005","journal-title":"BJU International"},{"issue":"6","key":"10.1002\/14651858.CD006744.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1464-410x.1999.00277.x","article-title":"Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. [comment]","volume":"84","author":"McNeill","year":"1999","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD006744.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1464-410X.2005.05685.x","article-title":"The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis","volume":"96","author":"Annemans","year":"2005","journal-title":"BJU International"},{"issue":"6 (Pt 1)","key":"10.1002\/14651858.CD006744.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000127743.80759.7a","article-title":"Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention","volume":"171","author":"McNeill","year":"2004","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD006744.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"83-9, discussio","DOI":"10.1016\/j.urology.2004.07.042","article-title":"Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study","volume":"65","author":"McNeill","year":"2005","journal-title":"Urology"},{"issue":"4","key":"10.1002\/14651858.CD006744.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0302-2838(02)00319-6","article-title":"Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention","volume":"42","author":"Shah","year":"2002","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB7|cit7","first-page":"35","article-title":"Alfuzosin XL prior to trial off catheter after acute urinary retention: early results from a randomized, double-blinded, placebo-controlled trial","volume":"13 Suppl 1","author":"Tibung","year":"2006","journal-title":"International Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD006744.pub2-BIB8|cit8","first-page":"516","article-title":"The outcome of trial off catheter after acute retention of urine","volume":"28","author":"Lim","year":"1999","journal-title":"Annals of the Academy of Medicine, Singapore"},{"issue":"1","key":"10.1002\/14651858.CD006744.pub2-BIB9|cit9","first-page":"32","article-title":"[Doxazosin in the gastrointestinal therapeutic system (GITS) formulation and trial without catheter after acute urinary retention due to BPH. Dose increase action on recovery effect]. [Spanish]","volume":"28","author":"Lorente Garin","year":"2004","journal-title":"Actas Urologicas Espanolas"},{"issue":"2","key":"10.1002\/14651858.CD006744.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1464-410X.1989.tb05160.x","article-title":"Trial without catheter following acute retention of urine [see comments]","volume":"63","author":"Taube","year":"1989","journal-title":"British Journal of Urology"},{"issue":"7","key":"10.1002\/14651858.CD006744.pub2-BIB11|cit11","first-page":"510","article-title":"[Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention]. [Chinese]","volume":"9","author":"Hua","year":"2003","journal-title":"Zhong Hua Nan Ke Xue"},{"key":"10.1002\/14651858.CD006744.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1464-410X.2005.05685.x","article-title":"The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis","volume":"96","author":"Annemans","year":"2005","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD006744.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"10-4, discussio","DOI":"10.1016\/S0022-5347(01)65267-4","article-title":"The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists","volume":"157","author":"Barry","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB14|cit14","unstructured":"British National Formulary 53, March 2007 British Medical Association. Royal Pharmaceutical Society of Great Britain"},{"key":"10.1002\/14651858.CD006744.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1464-410X.1975.tb03947.x","article-title":"Adrenergic and cholinergic receptors in the human prostate capsule and bladder neck","volume":"47","author":"Caine","year":"1975","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB16|cit16","first-page":"255","article-title":"The use of alpha-adrenergic blockers in benign prostatic obstruction","volume":"48","author":"Caine","year":"1976","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB17|cit17","first-page":"221","article-title":"The capsule in benign prostatic hypertrophy","volume":"87-2881","author":"Caine","year":"1987","journal-title":"Department of Health and Human Services, National Institute of Health Publication"},{"key":"10.1002\/14651858.CD006744.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.318.7188.921","article-title":"Acute urinary retention in men: an age old problem","volume":"318","author":"Emberton","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006744.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-199549020-00011","article-title":"Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia","volume":"49","author":"Fulton","year":"1995","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD006744.pub2-BIB20|cit20","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006744.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-5347(01)64508-7","article-title":"Natural history of prostatism: risk factors for acute urinary retention","volume":"158","author":"Jacobsen","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB22|cit22","first-page":"875","article-title":"The cost of complicated acute urinary retention: a patient chart analysis in Belgium]","volume":"60(11)","author":"Lamotte","year":"2005","journal-title":"Revue Medicale de Liege"},{"key":"10.1002\/14651858.CD006744.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride long-term efficacy and safety study group","volume":"338","author":"McConnel","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006744.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(05)68563-1","article-title":"Incidence rates and risk factors for acute urinary retention: the health professionals followup study","volume":"162","author":"Meigs","year":"1999","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB25|cit25","first-page":"468","article-title":"Acute urinary retention - a urodynamic assessment","volume":"56","author":"Murray","year":"1984","journal-title":"British Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD006744.pub2-BIB26|cit26","article-title":"Urinary catheter policies for long-term bladder drainage","author":"Ni\u00ebl-Weise","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006744.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1464-410x.1998.00632.x","article-title":"The management of men with acute urinary retention","volume":"81","author":"Pickard","year":"1998","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000020189","article-title":"Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS study group","volume":"37","author":"Roehrborn","year":"2000","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000049885","article-title":"Long-term aspects of medical treatment of BPH","volume":"40 Suppl 3","author":"Schulman","year":"2001","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD006744.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1464-410X.1989.tb05160.x","article-title":"Trial without catheter following acute retention of urine","volume":"63","author":"Taube","year":"1989","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD006744.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0302-2838(03)00084-8","article-title":"The natural history of lower urinary tract symptoms over five years","volume":"43","author":"Temml","year":"2003","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD006744.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1464-410X.2004.05254.x","article-title":"Acute urinary retention: what is the impact on patients' quality of life?","volume":"95","author":"Thomas","year":"2005","journal-title":"British Journal of Urology International"},{"issue":"4","key":"10.1002\/14651858.CD006744.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.eururo.2004.11.011","article-title":"Low incidence of acute urinary retention in the general male population: the triumph project","volume":"47","author":"Verhamme","year":"2005","journal-title":"European Urology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006744.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006744.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:03:12Z","timestamp":1628532192000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006744.pub2"}},"subtitle":[],"editor":[{"given":"Hans-Joerg","family":"Zeif","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006744.pub2","relation":{},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}